The largest database of trusted experimental protocols

Hamster igg

Manufactured by Jackson ImmunoResearch
Sourced in Panama

Hamster IgG is a laboratory reagent used in immunological research. It serves as a source of immunoglobulin G (IgG) antibodies derived from the hamster. IgG is a common class of antibodies found in the blood and other bodily fluids, and it plays a crucial role in the humoral immune response. The Hamster IgG product provides researchers with a reliable supply of this important biomolecule for their experimental needs.

Automatically generated - may contain errors

6 protocols using hamster igg

1

Flow Cytometry and Histology Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies with the following specificities used for flow cytometry and histology were purchased from BD Bioscience, eBioscience or Biolegend: CD45.2-biotin, Lamda Light chain-biotin, GFP- Alexa Fluor 488 (AL488), rabbit IgG-PE, CD38-PE-Cy7, CD95-PE-Cy7, BCL6-Al647, Streptavidin-Al700 or -Brilliant Violet 421 (BV421), CD45RA (B220)-allophycocyanin (APC)-Cy7, IRF4-eFluor 450. RelB (C19) was from Santa Cruz Biotech, rabbit IgG Fab2-Al555 was from Cell Signaling Technologies. Purified αCD40 (FGK4.5) (RRID: AB_2490239) and αCD40L (MR1) (RRID: AB_1612465) were purchased from BioXCell. AFRC-Mac-1 cell (glycoprotein of dog chlamydomonas) (RRID: CVCL_K178) (Sigma-Aldrich) produced Rat IgG2a istotype control was purified from culture supernatants by affinity chromatography, using a staphylococcal protein G column (ThermoFisher Scientific) and filter sterilized. Hamster IgG was from Jackson ImmunoResearch Laboratories.
+ Open protocol
+ Expand
2

Isolation and Characterization of Astrocytes and Microglia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Brains and spinal cords from transgenic GFAP-EGFP mice were dissociated using the papain-based neural tissue dissociation kit (Miltenyi Biotec, Germany). Myelin was separated from the cells on a discontinuous Percoll gradient (GE Healthcare Biosciences AB, Uppsala, Sweden) and the cells were washed and incubated with blocking solution containing HBSS, FBS (Sigma-Aldrich), anti-Fc receptor antibody (BD Biosciences, Brøndby, Denmark), hamster IgG (Jackson ImmunoResearch, West Grove, PA, USA), and sodium azide. The cells were then labeled with phycoerythrin (PE)-conjugated anti-CD45 (BD Biosciences) for 15 min at 4 °C and propidium iodide (PI, Sigma-Aldrich) to detect microglia/macrophages and non-viable cells, respectively.
Cells were sorted using a FACSVantage SE DiVa cell sorter (BD Biosciences). Astrocytes were defined as EGFP positive and CD45 negative (Fig. 6b). Microglia were defined as EGFP negative and CD45dim. Sorted astrocytes and microglia were re-analyzed by flow cytometry and quantitative real-time RT-PCR to verify purity.
+ Open protocol
+ Expand
3

Investigating PD-1 Blockade and IL-10 Inhibition in Murine Ovarian Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were inoculated with ID8 cells and on day 25 received either 200 μg hamster IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) or 200 μg G4 clone PD-1–blocking monoclonal antibody i.p. as described (21 (link), 22 (link)). Mice were treated until moribund up to 11 treatments (8 - 11 times up to 7 weeks). IL-10 neutralizing antibody (BioLegend, San Diego, CA) and IL-10R antagonist antibody (BD Pharmingen, San Diego, CA) were injected i.p alternating between the two antibodies at a concentration of 100 μg and 200 μg per mouse, respectively. The same amount of isotype matched antibodies (Rat IgG1κ or Rat IgG1χ) from the respective suppliers was injected in the control groups. Tumor and ascites were harvested as necessary when mice were moribund.
+ Open protocol
+ Expand
4

Blocking PD-L1 and IFN-γ in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse PD-L1 (B7-H1) monoclonal antibody (clone 10B5) was purified on a protein G column from the supernatant of the hybridoma cell line (kindly provided by Dr Lieping Chen from Yale University). Anti-PD-L2 blocking Ab (clone TY25) was purchased from Bio-X-Cell. Control Abs (hamster IgG and Rat IgG) were obtained from Jackson ImmunoResearch Laboratories. The blocking Abs were injected IP with a dose of 1.2 mg per mouse at 4 d.p.i. and 600 μg per mouse at 6 d.p.i., respectively. Neutralizing IFN-γ Ab (clone XMG1.2, Bio-X-Cell, West Lebanon, NH) was injected IP at dose of 1 mg per mouse.
+ Open protocol
+ Expand
5

Subconjunctival Immunotherapy for Ocular Transplants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The recipient mice were randomized to receive subconjunctival injections of either hamster anti-mouse Itga-9 antibody (6.4 μg; kindly provided by Toshimitsu Uede, MD, PhD, Hokkaido University, Hokkaido, Japan) or its isotype control hamster IgG (Jackson ImmunoResearch, West Grove, PA, USA), as reported previously.11 (link) Subconjunctival injection was performed twice a week on the day of transplantation and thereafter up to 8 weeks after the surgery.
+ Open protocol
+ Expand
6

Neutralizing Anti-Mouse FKN Monoclonal Antibody

Check if the same lab product or an alternative is used in the 5 most similar protocols
The anti‐mouse FKN mAb (clone 5H8‐4), which is a highly specific neutralizing mAb(19, 20, 21) used in this study, was generated by immunizing Armenian hamsters with recombinant mouse FKN (R&D Systems, Minneapolis, MN).(19) Isotype‐matched hamster IgG was generated in Armenian hamsters immunized with 2,4‐dinitrophenol, as previously described.(19, 21) For some analyses, we used rat anti‐mouse FKN mAb (clone 126315) and rat IgG2A isotype control (clone 54447) purchased from R&D Systems and hamster IgG from Jackson ImmunoResearch Inc. (West Grove, PA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!